Member Info for andinio

Looking at the recent daily sp movements, if this doesn't break 19p today there could be a further test of shareholder resolve between mid to high 17p and 19p.
If ever there was a time to fold your arms and sit tight, it's Winter 2020.

...only to jump back on again, at a potential premium.

Demon_G
Precisely. Govt support or public funding initiative.
Orph are calving a dual pathway: conventional and covid.

Brooko_19
I think Open Orphan are going to be granted a Michelin style kitchen to allow them to produce outstanding food.

KTRB.
Inline with my calcs.

19p target is blown out of the water IMO.
Todays RNS confirms the presentation comments we've all heard.
We're heading towards new territory.
Still, patience required. It wont be overnight. Steady and onward.

Personally, i think todays RNS is the most significant this yr.
There's a litter of statements and confirmations well beyond the contract announcement.
The journey is about to commence. IMO.

Yes, but it's first time announced via RNS.
Big difference.

QU booked out until Dec 2021 with CONVENTIONAL studies. Covid bookings yet to come on top!

Quote:
With this contract, we are close to having the hVIVO quarantine clinic block booked with our conventional challenge studies until December 2021

Month-on-month locking in SP value.

Open Orphan.... pleased to announce a new £4.3 million contract to conduct a human viral challenge study utilising one of our 8 traditional challenge study models for another of the global top 10 vaccine companies.

I'm happy :)

OK123

1. Open Orphan were named within the FT article.
2. It's hVivo, not nVivo.

ref:
The project’s academic leader is Imperial College London, and it will be run by hVivo, a spinout from Queen Mary University of London that was bought earlier this year by Open Orphan, a Dublin-based pharmaceutical research organisation.

Deepoy.
Exactly. My thoughts too.

For what it's worth, i see Orph leading the studies over multple sites - with potential for sites to be partially/fully funded through Gov or public interest initiatives.
Either way, i see the challenge study concept being embraced by Gov et al with effort being in abundance to lay a clear pathway.

So, next week we have:
1. Share presentation
2. H1 results
3. Likely/possible announcement around challenge study & Gov
Oct, Nov, December could be thrilling.

I thought it would run up to 20.20 and then fall back - finishing to mid 18p close.
Having said that, the day isn't over just yet :)

It's been quite a wait for some PIs so some profit slicing.
Some may see circa 19p as sell point.
Buys will flow in when profit slicing fades. Long and clear road ahead :)

Agreed.
...and todays news reduces possibility.